AZN

AstraZeneca PLC

Price

$204.64

return (12m)

p/e

25.20

p/bv

5.52

DIVIDEND YIELD

1.89%

AZN price

AstraZeneca

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AZN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals AZN

Valuation

P/E

25.20

Sector -4.15

Industry -4.15

P/BV

5.52

Sector 2.06

Industry 2.06

P/Revenue (PSR)

4.33

Sector -4.16

Industry -4.16

EV/EBITDA

49.10

Sector -241.86

Industry -241.86

EV/EBIT

64.68

Sector -671.75

Industry -671.75

P/EBITDA

12.94

Sector -4.30

Industry -4.30

P/EBIT

17.85

Sector -4.35

Industry -4.35

P/Total Assets

2.30

Sector 1.46

Industry 1.46

P/Net Current Assets

-7.07

Sector -12.67

Industry -12.67

P/Working Capital

-88.53

Sector -12.58

Industry -12.58

EPS

6.71

Sector -2.19

Industry -2.19

BVPS

30.59

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

81.68%

Sector 36.44%

Industry 36.44%

EBITDA Margin

37.11%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

28.17%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

23.69%

Sector -38.78%

Industry -38.78%

Net Profit Margins

17.19%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.13

Sector 0.03

Industry 0.03

Profitability

ROE

21.93%

Sector -67.01%

Industry -67.01%

ROA

9.11%

Sector -66.28%

Industry -66.28%

ROIC

13.26%

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

1.89%

Sector -

Industry -

Payout

47.63%

Sector -

Industry -

Debt

Current Ratio

0.91

Sector 2.90

Industry 2.90

Net Debt / EBITDA

2.96

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

3.90

Sector -3.79

Industry -3.79

Net Debt / Equity

0.35

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

0.52

Sector 0.00

Industry 0.00

Equity/Assets

0.42

Sector 0.42

Industry 0.42

Liabilities/Assets

0.58

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

10.07%

Sector -

Industry -

5Y Earnings CAGR

147.44%

Sector -

Industry -

FAIR VALUE OF AstraZeneca ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$204.64

Fair Value

$67.96

Upside Return potential.

-66.79%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals AZN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AZN Historical Dividends

current DY: 1.89%

5-year average DY: 2.26%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/20/2026	03/23/2026	2.17570000
Dividends	08/08/2025	09/08/2025	0.51500000
Dividends	02/21/2025	03/24/2025	1.05000000
Dividends	08/09/2024	09/09/2024	0.50000000
Dividends	02/23/2024	03/25/2024	0.98500000
Dividends	08/11/2023	09/11/2023	0.46500000
Dividends	02/24/2023	03/27/2023	0.98500000
Dividends	08/12/2022	09/12/2022	0.46500000
Dividends	02/25/2022	03/28/2022	0.98500000
Dividends	08/13/2021	09/13/2021	0.45000000
Dividends	02/26/2021	03/29/2021	0.95000000
Dividends	08/14/2020	09/14/2020	0.45000000
Dividends	02/28/2020	03/30/2020	0.95000000
Dividends	08/09/2019	09/09/2019	0.45000000
Dividends	03/01/2019	03/27/2019	0.95000000
Dividends	08/10/2018	09/10/2018	0.45000000
Dividends	02/16/2018	03/19/2018	0.95000000
Dividends	08/11/2017	09/11/2017	0.45000000
Dividends	02/17/2017	03/20/2017	0.95000000
Dividends	08/12/2016	09/12/2016	0.45000000
Dividends	02/19/2016	03/21/2016	0.95000000
Dividends	08/14/2015	09/14/2015	0.45000000
Dividends	02/20/2015	03/23/2015	0.95000000
Dividends	08/15/2014	09/15/2014	0.45000000
Dividends	02/21/2014	03/24/2014	0.95000000
Dividends	08/16/2013	09/16/2013	0.45000000
Dividends	02/15/2013	03/18/2013	0.95000000
Dividends	08/10/2012	09/10/2012	0.45000000
Dividends	02/17/2012	03/19/2012	0.97500000
Dividends	08/08/2011	09/12/2011	0.42500000
Dividends	02/04/2011	03/14/2011	0.92500000
Dividends	08/06/2010	09/13/2010	0.35000000
Dividends	02/05/2010	03/15/2010	0.85500000
Dividends	08/07/2009	09/14/2009	0.29500000
Dividends	02/06/2009	03/16/2009	0.75000000
Dividends	08/08/2008	09/15/2008	0.27500000
Dividends	02/11/2008	03/17/2008	0.67500000
Dividends	08/10/2007	09/17/2007	0.26000000
Dividends	02/09/2007	03/19/2007	0.61500000
Dividends	08/11/2006	09/18/2006	0.24500000
Dividends	02/10/2006	03/20/2006	0.46000000
Dividends	08/12/2005	09/19/2005	0.19000000
Dividends	02/11/2005	03/21/2005	0.32250000
Dividends	08/13/2004	09/20/2004	0.14750000
Dividends	02/20/2004	04/06/2004	0.27000000
Dividends	08/22/2003	10/06/2003	0.12750000
Dividends	02/21/2003	04/07/2003	0.26100000
Dividends	08/23/2002	10/07/2002	0.12800000
Dividends	02/20/2002	04/08/2002	0.26100000
Dividends	08/22/2001	10/05/2001	0.12800000
Dividends	02/23/2001	04/09/2001	0.26100000
Dividends	09/08/2000	10/23/2000	0.12800000
Dividends	03/10/2000	04/17/2000	0.26100000
Dividends	09/10/1999	10/25/1999	0.12800000
Dividends	04/09/1999	04/28/1999	0.17500000

ABOUT AstraZeneca

AstraZeneca PLC

Average Investor10 user rating

4.0 (2 people)

States of America

34 years

Founded: 1992

1993

Time since IPO - 33 years

74.800

Employees

AstraZeneca PLC (States of America) is listed on the Nasdaq and has a market capitalization of $261.78 billion, with shareholders equity totaling $47.38 billion.

The company employs approximately 74.800 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, AstraZeneca PLC reported $60.44 billion in revenue, generating net income of $10.39 billion.

Key financial metrics include a P/E ratio of 25.20, a price-to-book (P/B) ratio of 5.52, and a trailing twelve-month dividend yield of 1.89%.

The company trades under the ticker AZN.

Market cap

$261.78 billion

Net worth

$47.38 billion

$47,384,000,000.00

Assets

$114.02 billion

$114,015,000,000.00

Total Shares Outstanding

1.55 billion

1,549,000,000

Average Daily Trading Volume

$2.22 million

$2,216,806.00

Sector

Healthcare

Industry

Biotecnologia

AZN

AZN revenue and profits

Financial Results AZN

DRAG THE FRAME TO SEE MORE DATA

AZN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14

PFE - Pfizer

$27.11 17,37% (12M)

P/E

18.76

6.97%

ROE

8.29%

P/BV

1.55